CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 14 filers reported holding CALLIDITAS THERAPEUTICS AB in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $487,323 | +13.1% | 26,688 | -1.9% | 0.30% | +20.2% |
| Q2 2023 | $431,053 | -35.3% | 27,214 | -2.1% | 0.25% | -40.4% |
| Q1 2023 | $666,246 | +49.0% | 27,795 | +5.6% | 0.42% | +41.0% |
| Q4 2022 | $447,253 | +2.6% | 26,309 | -8.5% | 0.30% | -3.3% |
| Q3 2022 | $436,000 | -14.7% | 28,742 | -0.1% | 0.30% | -10.8% |
| Q2 2022 | $511,000 | -7.3% | 28,763 | +0.0% | 0.34% | +14.4% |
| Q1 2022 | $551,000 | -18.4% | 28,762 | +5.5% | 0.30% | -10.5% |
| Q4 2021 | $675,000 | +12.1% | 27,267 | -2.0% | 0.33% | +7.1% |
| Q3 2021 | $602,000 | +28.6% | 27,836 | +75.2% | 0.31% | +32.2% |
| Q2 2021 | $468,000 | – | 15,890 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 144,393 | $4,252,000 | 1.17% |
| BVF INC/IL | 750,000 | $22,080,000 | 0.83% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 15,890 | $468,000 | 0.24% |
| Vivo Capital, LLC | 62,306 | $1,835,000 | 0.08% |
| Pentwater Capital Management LP | 50,000 | $1,473,000 | 0.01% |
| NEXT Financial Group, Inc | 4,458 | $131,000 | 0.01% |
| Advisory Services Network, LLC | 3,369 | $99,000 | 0.00% |
| DEUTSCHE BANK AG\ | 71,531 | $2,107,000 | 0.00% |
| JANE STREET GROUP, LLC | 7,216 | $211,000 | 0.00% |
| UBS Group AG | 11 | $0 | 0.00% |